Treatment with low-dose interferon-alpha in Bulgarian HBeAg-negative patients with chronic hepatitis B

被引：1
|
作者：
Krastev, Z [1 ]
Antonov, K [1 ]
Vassilev, M [1 ]
Jelev, D [1 ]
机构：
[1] Med Univ Sofia, Gastroenterol Clin, Sofia, Bulgaria
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 1998年 / 27卷 / 04期
关键词：
D O I：
10.1097/00004836-199812000-00021
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：367 / 368
页数：2
相关论文
共 50 条
  • [31] Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Kwak, Min-Sun
    Cho, Eun Ju
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    DIGESTION, 2011, 84 : 23 - 28
  • [32] Natural history of HBeAG-negative chronic hepatitis B
    Ghany M.G.
    Liang T.J.
    Current Hepatitis Reports, 2006, 5 (1) : 27 - 32
  • [33] Progress in HBeAg-negative chronic hepatitis B therapy
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 (1): : 11 - 11
  • [34] APPLICATION OF ALPHA-FETOPROTEIN TO IDENTIFY PATIENTS WHO NEED ANTIVIRAL TREATMENT IN HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Huang, Yi-Hsiang
    Lee, I-Cheng
    Chan, Che-Chang
    Huo, Teh-la
    Su, Chien-Wei
    Lin, Han-Chieh
    Lee, Shou-Dong
    HEPATOLOGY, 2010, 52 (04) : 547A - 547A
  • [35] LOW-DOSE INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA
    TALPAZ, M
    KANTARJIAN, H
    ANNALS OF INTERNAL MEDICINE, 1995, 122 (09) : 728 - 728
  • [36] Low liver cell proliferation and high apoptosis rates in patients with HBEAG-negative chronic hepatitis B responding to interferon.
    Donato, MF
    Arosio, E
    Lampertico, P
    Maggiore, O
    Trerè, D
    Viganò, M
    Iavarone, M
    Derenzini, M
    Colombo, M
    HEPATOLOGY, 2004, 40 (04) : 267A - 267A
  • [37] The impact of interferon-alfa (IFNa) therapy on liver histology in patients with HBeAg-negative chronic hepatitis B [HBeAg(-)CHB].
    Papatheodoridis, GV
    Cholongitas, E
    Kanta, E
    Petraki, K
    Ketikoglou, I
    Manesis, EK
    HEPATOLOGY, 2003, 38 (04) : 712A - 712A
  • [38] A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
    Chen, Xinyue
    Mao, Qianguo
    Xie, Yao
    Dou, Xiaoguang
    Xie, Qing
    Sheng, Jifang
    Gao, Zhiliang
    Zhou, Xiaoling
    Liu, Yingxia
    Zheng, Huanwei
    Zhang, Shuqin
    Li, Shibo
    Zhu, Fusheng
    Xu, Yuqin
    Zhang, Mingxiang
    Hu, Yaoren
    Chen, Xiaoping
    Huang, Yan
    Ren, Hong
    Jia, Jidong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 249 - 257
  • [39] Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy
    Hadziyannis, SJ
    JOURNAL OF HEPATOLOGY, 2002, 36 (02) : 280 - 282
  • [40] The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
    Papatheodoridis, GV
    Manesis, E
    Hadziyannis, SJ
    JOURNAL OF HEPATOLOGY, 2001, 34 (02) : 306 - 313
12345